Profile for Juno Therapeutics, Inc. (JUNO)
« Back to company indexJUNO Chatter Timeline
Stock Ticker for JUNO
Most Active Tweeters for JUNO
| User | Tweets |
|---|---|
| @TickerReport | 12 |
| @chaffeybreeze | 12 |
| @IRAMarketReport | 11 |
| @WatchlistN | 9 |
| @1MinuteStock | 8 |
Recent Tweets for JUNO
 |
@BursatilBiotech @sergiogdealba @DrPaulyDeSantis do you prefer ctl.019 than jcar17? Not in my case, still stick to $juno's science, not management July 19th 2017, 9:07pm |
 |
@MikeMarcus15 $JUNO Pullback over ? Let's not forget unanimous FDA advisors decision on Novartis candidate. Fresh hope for immunotherapy. July 19th 2017, 4:07pm |
 |
@MaisaCorp $JUNO $28.23 +0.61 (2.21%) - on a run since mid #June2017 July 19th 2017, 4:07pm |
 |
@chaffeybreeze Juno Therapeutics, Inc. $JUNO Stake Raised by Credit Suisse AG https://t.co/RLGdyNprp8 July 19th 2017, 3:07pm |
 |
@dakotafinancial Zacks: Brokerages Anticipate Juno Therapeutics, Inc. $JUNO Will Announce Quarterly Sales of $17.18 Million https://t.co/GRf5786lGw July 19th 2017, 2:07pm |
 |
@SleekMoneycom Zacks: Brokerages Anticipate Juno Therapeutics, Inc. $JUNO Will Announce Quarterly Sales of $17.18 Million https://t.co/1rna2IQdVh July 19th 2017, 2:07pm |
 |
@intercooleronli Zacks: Brokerages Anticipate Juno Therapeutics, Inc. $JUNO Will Announce Quarterly Sales of $17.18 Million https://t.co/wPwgip1k0y July 19th 2017, 2:07pm |
|
@BursatilBiotech @DrPaulyDeSantis This guy is the SAME one who sold BEFORE the CO released first neg data on ROCKET trial $JUNO. &… https://t.co/u6urJcveXM July 19th 2017, 2:07pm |
 |
@IRAMarketReport Douglas K. Bratton Sells 8,000,000 Shares of Juno Therapeutics, Inc. $JUNO Stock https://t.co/uTmuHP9zLq July 19th 2017, 12:07pm |
|
@chaffeybreeze Douglas K. Bratton Sells 8,000,000 Shares of Juno Therapeutics, Inc. $JUNO Stock https://t.co/IFauf2nfbA July 19th 2017, 12:07pm |
 |
@asymmetricalpha $JUNO Bull reversal. Gap up https://t.co/Ut3GGwyIK2 https://t.co/YDwl2mrSfW July 19th 2017, 9:07am |
 |
@dailymailtimes Juno Therapeutics, Inc. $JUNO Upgraded to Buy at Vetr Inc. https://t.co/7Iy0G2MRFQ July 19th 2017, 8:07am |
|
@asymmetricalpha $JUNO Oversold conditions at support https://t.co/Ut3GGwyIK2 https://t.co/0xisOhql9X July 19th 2017, 8:07am |
 |
@BioWino RT @insider_daily: . for a total of $216,000,000.00. The entity owns 9,166,130 shares of $JUNO Common Stock following this transaction. Rep… July 19th 2017, 7:07am |
|
@BioWino RT @insider_daily: On 2017-07-13, BRATTON DOUGLAS K, 10% Owner of Juno Therapeutics $JUNO, sold 8,000,000 shares at an average price of $27… July 19th 2017, 7:07am |
 |
@StockConsultant $JUNO (JUNO) Juno Therapeutics stock back to 27.41 support area w/ bullish stats https://t.co/Wc47S48VUp July 19th 2017, 7:07am |
 |
@ProVesting $CLDX $JUNO: Better Buy: Celldex Therapeutics, Inc. vs. Juno Therapeutics: https://t.co/AWUjsJiqO2 July 19th 2017, 6:07am |
 |
@dailypoliticaln Juno Therapeutics, Inc. $JUNO Upgraded to Buy at Vetr Inc. https://t.co/CjsI5aOAcK July 19th 2017, 2:07am |
 |
@midetimes Juno Therapeutics, Inc. $JUNO Upgraded to Buy at Vetr Inc. https://t.co/CpT5nUKVQv July 19th 2017, 2:07am |
 |
@Dougallan1 $JUNO CEO Hans Bishop joins board of Agilent https://t.co/OIAGT3Jf5g July 18th 2017, 9:07pm |
 |
@pawcio2009 He jinxed $juno 2015 #cramerkissofdeath https://t.co/ag0CUJCAnD July 18th 2017, 5:07pm |
 |
@insider_daily On 2017-07-13, BRATTON DOUGLAS K, 10% Owner of Juno Therapeutics $JUNO, sold 8,000,000 shares at an average price of $27.00 per share ... July 18th 2017, 3:07pm |
|
@insider_daily . for a total of $216,000,000.00. The entity owns 9,166,130 shares of $JUNO Common Stock following this transaction. Reported on 2017-07-18. July 18th 2017, 3:07pm |
 |
@TheMarketsDaily Juno Therapeutics, Inc. $JUNO Major Shareholder Douglas K. Bratton Sells 8,000,000 Shares https://t.co/jWLmQr0WMw July 18th 2017, 2:07pm |
 |
@dhovekamp42 RT @WatchlistN: Juno Therapeutics, Inc. $JUNO Major Shareholder Douglas K. Bratton Sells 8,000,000 Shares https://t.co/yuRVLSfIv5 July 18th 2017, 12:07pm |
 |
@WatchlistN Juno Therapeutics, Inc. $JUNO Major Shareholder Douglas K. Bratton Sells 8,000,000 Shares https://t.co/yuRVLSfIv5 July 18th 2017, 12:07pm |
 |
@cells_nnm @fredhutch CAR-T trial results in CLL is out https://t.co/iuVNaAUGuq compare to Penn's results from 2015 https://t.co/fuxorLncd9 $JUNO July 18th 2017, 9:07am |
 |
@Brandon555577 $JUNO - Amended Statement of Beneficial Ownership (sc 13d/a) https://t.co/1yQ6yhkHHl July 18th 2017, 6:07am |
 |
@fintel_io BRATTON DOUGLAS K has decreased their shares in $JUNO by 46% since their previous 13D/G filing - https://t.co/WuwCjkYvcn July 18th 2017, 6:07am |
 |
@ScatmanGL RT @intercooleronli: Insider Selling: Juno Therapeutics, Inc. $JUNO Major Shareholder Sells 8,000,000 Shares of Stock https://t.co/RnIQF32f… July 17th 2017, 9:07pm |
|
@ScatmanGL Something is up. $JUNO big insider sell. July 17th 2017, 9:07pm |
 |
@TranscriptDaily Juno Therapeutics, Inc. $JUNO Upgraded at Zacks Investment Research https://t.co/jk9w8XGA1Y July 17th 2017, 9:07pm |
 |
@theborg73 RT @AurMuses: For the ones holding $JUNO.. https://t.co/9Q5If2cY5D July 17th 2017, 8:07pm |
|
@intercooleronli Insider Selling: Juno Therapeutics, Inc. $JUNO Major Shareholder Sells 8,000,000 Shares of Stock https://t.co/RnIQF32fTS July 17th 2017, 7:07pm |
|
@IRAMarketReport BidaskClub Lowers Juno Therapeutics, Inc. $JUNO to Buy https://t.co/ek0I7vcDHY July 17th 2017, 7:07pm |
|
@chaffeybreeze BidaskClub Lowers Juno Therapeutics, Inc. $JUNO to Buy https://t.co/9xGVpSZ5DM July 17th 2017, 7:07pm |
 |
@WKRBNews BidaskClub Lowers Juno Therapeutics, Inc. $JUNO to Buy https://t.co/CxrJnOCnX1 July 17th 2017, 7:07pm |
|
@WKRBNews BidaskClub Lowers Juno Therapeutics, Inc. $JUNO to Buy https://t.co/JQsvIK1moh July 17th 2017, 7:07pm |
 |
@AurMuses For the ones holding $JUNO.. https://t.co/9Q5If2cY5D July 17th 2017, 7:07pm |
 |
@InsiderAlertsIA $JUNO: New Insider Filing on 10%+ Owner BRATTON DOUGLAS K: https://t.co/7ttmHNblwQ July 17th 2017, 6:07pm |
|
@Brandon555577 $JUNO - Statement of Changes in Beneficial Ownership (4) https://t.co/3y6fjPt1yv July 17th 2017, 5:07pm |
|
@TheMarketsDaily -$0.74 EPS Expected for Juno Therapeutics, Inc. $JUNO This Quarter https://t.co/ZXhAejfxAZ July 17th 2017, 1:07pm |
|
@WatchlistN -$0.74 EPS Expected for Juno Therapeutics, Inc. $JUNO This Quarter https://t.co/42E9CjmxDX July 17th 2017, 12:07pm |
|
@IRAMarketReport Creative Planning Acquires 2,811 Shares of Juno Therapeutics, Inc. $JUNO https://t.co/3GKXZvqnmw July 17th 2017, 11:07am |
|
@chaffeybreeze Creative Planning Acquires 2,811 Shares of Juno Therapeutics, Inc. $JUNO https://t.co/bJQJ3NrY8a July 17th 2017, 11:07am |
 |
@TradeByProfile $JUNO held support at low volume node near 27. Swing trade long with a tight stop. https://t.co/7q8WuwhTQh July 17th 2017, 11:07am |
 |
@tymorapro $JUNO: At 1DyHIGH=27.75, hits:2, ch:+1.8%, 0phNearHi, tf:0111111, medFlt:62M, HiPctSht[26%:6d], DyVol:230T:0.1x:0.1x, DyRng:1.5%:0.5x:0.3x July 17th 2017, 10:07am |
 |
@storminvestor Juno Therapeutics $JUNO Receives Daily Media Sentiment Rating of 0.02 https://t.co/RDRCkauU8C July 17th 2017, 10:07am |
 |
@SPNewsAnalysis Juno Therapeutics $JUNO Receives Daily Media Sentiment Rating of 0.02 https://t.co/VROrJQwfQ1 July 17th 2017, 10:07am |
 |
@sesiegler @JeffBezos I will help you despite $JUNO being my competitor. I studied the Challenger and Columbia disasters. July 17th 2017, 8:07am |
Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.